Table 1. Uterine weight.
Experiment 1 | |||||
EB dose | EB0S | EB0.5S | EB5S | EB50S | |
Uterine weight (mg) | 29.6 ± 2.0a | 36.8 ± 2.6 | 41.9 ± 4.4 | 52.9 ± 6.2b | |
Experiment 2 | |||||
EB dose | EB0L | EB0.05L | EB0.5L | EB5L | EB50L |
Uterine weight (mg) | 27.8 ± 1.4a | 25.3 ± 1.2a | 51.9 ± 7.7a | 173.6 ± 24.8b | 193.7 ± 13.9b |
Uterine weights after the test in Experiment 1 and Experiment 2. The weights were measured 5 days after a single administration of EB in Experiment 1, and 17 days after implantation of EB capsules in Experiment 2. The uterine weights increased in line with the EB dose administered. The superscript letters indicate statistical significance; ps < 0.01.